NASDAQ:BWV - Nasdaq - US09610B1089 - Common Stock - Currency: USD
0.1802
-0.01 (-5.16%)
The current stock price of BWV is 0.1802 USD. In the past month the price decreased by -41.89%. In the past year, price decreased by -82.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.97 | 357.10B | ||
AMGN | AMGEN INC | 15.29 | 162.72B | ||
GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
NTRA | NATERA INC | N/A | 21.43B | ||
BIIB | BIOGEN INC | 8.54 | 20.49B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on developing transformational therapies to address significant health challenges globally. The firm is engaged in developing a streptococcus pneumonia vaccine candidate, designed to specifically prevent highly infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The firm is also developing a universal flu vaccine that provides protection from all virulent strains in addition to licensing a norovirus (NoV) shell and protrusion (S&P) nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others. In addition, the Company is developing a Chlamydia vaccine candidate with the University of Texas Health Science Center in San Antonio (UT Health).
BLUE WATER BIOTECH INC
201 E. Fifth Street, Suite 1900
Cincinnati OHIO US
Employees: 12
Company Website: https://www.bluewatervaccines.com
Phone: 15136204101
The current stock price of BWV is 0.1802 USD. The price decreased by -5.16% in the last trading session.
The exchange symbol of BLUE WATER BIOTECH INC is BWV and it is listed on the Nasdaq exchange.
BWV stock is listed on the Nasdaq exchange.
8 analysts have analysed BWV and the average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802. Check the BLUE WATER BIOTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BLUE WATER BIOTECH INC (BWV) currently has 12 employees.
BLUE WATER BIOTECH INC (BWV) has a resistance level at 0.22. Check the full technical report for a detailed analysis of BWV support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BWV does not pay a dividend.
BLUE WATER BIOTECH INC (BWV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).
Over the last trailing twelve months BWV reported a non-GAAP Earnings per Share(EPS) of -0.86. The EPS decreased by -2.75% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -65.6% | ||
ROE | -178.61% | ||
Debt/Equity | 1.26 |
ChartMill assigns a Buy % Consensus number of 45% to BWV. The Buy consensus is the average rating of analysts ratings from 8 analysts.